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BNIP3; cardiac myocytes; mitochondria; autophagy; apoptosis; oxidative stress THE ATYPICAL BH3-only protein Bcl-2/adenovirus E1B 19-kDa interacting protein 3 (BNIP3) is a proapoptotic member of the BCL-2 family. BNIP3 is localized primarily to the mitochondria, where it induces cell death via activation of BAX/BAK and opening of the mitochondrial permeability transition pore (22, 33, 38) . BNIP3 is upregulated during hypoxia by the transcription factor hypoxia-inducible factor-1 and plays a role in hypoxia-mediated cell death in many different cell types, including neonatal myocytes (2, 10, 33) . Paradoxically, some cells are resistant to death caused by overexpression of BNIP3 (1, 30, 37) ; in some other cell types, BNIP3 causes slower and more modest cell death than other BH3-only proteins (32, 39) .
It is unclear why some cells are more resistant to BNIP3-mediated cell death.
Recent studies have found that BNIP3 also regulates mitochondrial morphology and autophagy (mitophagy) in cells (6, 9) . Specifically, BNIP3 promotes fission of mitochondria by its interaction with OPA1 (23) . BNIP3 also functions as an autophagy receptor on mitochondria, where its microtubuleassociated protein 1 light chain (LC) 3-interacting region tethers mitochondria to autophagosomes (11, 24) . The proautophagy function of BNIP3 is independent of its prodeath activity (11) , but how BNIP3 switches between these seemingly opposing functions is unclear.
There is increasing evidence that deregulation of BNIP3 plays a role in human disease. For instance, BNIP3 expression is downregulated in malignant glioma (4) and gastrointestinal malignancies (18, 29) , which renders these cells more resistant to chemotherapy. In contrast, elevated BNIP3 expression in non-small-cell lung carcinoma and ductal carcinoma of the breast correlates with a more aggressive tumor (8, 36) . In addition, BNIP3 contributes to loss of myocytes during myocardial ischemia (10, 19, 33) and to the remodeling process after a myocardial infarction (5) . Because of its implication in human disease, BNIP3 signifies an important potential future therapeutic target. Therefore, it is critical to increase our understanding of how BNIP3 regulates survival and death in different cells.
Infants with congenital heart defects often require corrective surgery to ensure survival. Several studies have found that the pediatric heart is more vulnerable than the adult heart to ischemic injury, which can occur during repair of congenital heart disease (12, 17) . The underlying mechanism(s) for this difference in susceptibility to ischemic injury between pediatric and adult hearts is unknown. BNIP3 is a well-known contributor to hypoxia-mediated cell death, but no studies have examined whether there are mechanistic differences in BNIP3-mediated cell death between neonatal and adult myocytes. In this study we discovered that BNIP3 is a potent mediator of cell death in neonatal myocytes, whereas adult myocytes are resistant to BNIP3-mediated cell death as a result of increased antioxidant capacity.
MATERIALS AND METHODS
Cardiac myocyte isolation and cell culture. All animal experiments were performed in accordance with institutional guidelines and approved by the Animal Care and Use Committee of the University of California, San Diego. Adult cardiac myocytes were isolated from 250-to 300-g male Sprague-Dawley rats, as previously described (21) . Briefly, hearts were quickly excised, cannulated via the aorta, and perfused with heart medium [Joklik-modified MEM supple- mented with 10 mM HEPES, 30 mM taurine, 2 mM carnitine, 2 mM creatine, and 0.1% collagenase II (Worthington Biochemicals, Lakewood, NJ) plus 0.1% BSA and 25 M CaCl 2]. After digestion, the ventricles were minced and myocytes were dispersed by gentle pipetting. Cells were filtered through a nylon mesh and washed twice at 100 g for 1 min. Calcium was reintroduced to select for calciumtolerant cells. The cells were plated on laminin-coated dishes for experiments in plating medium (medium 199 supplemented with 10 mM HEPES, 5 mM taurine, 2 mM carnitine, 5 mM creatine, and 0.2% fatty acid-free BSA). After 1 h of plating, myocytes were infected with adenovirus. Neonatal cardiac myocytes were isolated from 1-to 2-day-old Sprague-Dawley rat pups, digested with collagenase, and purified by a Percoll gradient (13) . Myocytes were plated at a density of 3.5 ϫ 10 4 /cm 2 and maintained overnight in 4:1 Dulbecco's modified Eagle's medium (DMEM)-medium 199, supplemented with 10% horse serum, 5% fetal calf serum, and antibiotics (100 U/ml penicillin and 100 g/ml streptomycin). Cells were used for experiments on the following day.
Adenoviral infections. Cultured neonatal and adult myocytes were infected with the adenovirus for 3 h in plating medium and DMEM ϩ 2% heat-inactivated FBS, respectively. After infection, the cells were washed and then incubated in regular cell culture medium for 21 h.
Fluorescence microscopy analysis. For measurement of mitochondrial membrane potential, myocytes overexpressing ␤-galactosidase (␤-gal) or BNIP3 were stained with 100 nM tetramethylrhodamine Hypoxia experiments. After 24 h of infection with ␤-gal, BNIP3⌬TM, or MnSOD, the medium was changed to DMEM high glucose (Invitrogen) saturated with 95% N 2-5% CO2, and neonatal cardiac myocytes were placed in a hypoxic chamber (Billups-Rothenberg). The hypoxic chamber was flushed with 95% N2-5% CO2 for 10 min, sealed, and placed in the 37°C incubator for 30 h. Control cells were cultured at 37°C in 5% CO2. DNA fragmentation was detected using the cell death detection ELISA PLUS (Roche Applied Science), as previously described (35) . Briefly, cells were washed with ice-cold PBS twice and harvested in cytosolic extraction buffer, nutated at 4°C for 10 min, and spun down at 20,000 g for 3 min, and supernatants were saved. Cell lysates were incubated with anti-histone-biotin antibody and anti-DNA-peroxidase antibody in a streptavidin-coated 96-well plate on a rocking shaker at room temperature for 2 h. Wells were washed with incubation buffer three times, and 2,2=-azino-bis(3-ethylbenzthiazoline-6-sulfonic) acid substrate was added. Absorbance was measured at 405 nm using an Infinite M200 PRO plate reader (Tecan).
Oxidative stress experiments. Adult cardiac myocytes overexpressing ␤-gal or BNIP3 were treated with 100 M H 2O2 for 3 h. For study of mitochondrial membrane potential and cell death, cells were stained with TMRM and YO-PRO-1, respectively. To inhibit Mn-SOD, adult cardiac myocytes were infected with Ad-␤-gal or Ad-BNIP3 in the presence of 100 M 2-methoxyestradiol (2-ME; catalog no. M6383, Sigma Aldrich), 5 M MitoTEMPO, or 10 M manganese (III) tetrakis (4-benzoic acid) porphyrin chloride (MnTBAP) for 24 h.
Western blotting. Cells were lysed in ice-cold buffer containing 50 mM Tris·HCl, pH 7.4, 150 mM NaCl, 12 mM Na-deoxycholate, and 1% Triton X-100 plus complete protease inhibitor cocktail (Roche Applied Science) and then cleared by centrifugation at 20,000 g for 20 min. Proteins were separated by SDS-PAGE under reducing conditions, transferred to nitrocellulose, and incubated with antibodies [BNIP3 (Sigma-Aldrich; 1:1,000 dilution), LC3 (Cell Signaling; 1:1,000 dilution), MnSOD (Thermo Scientific; 1:1,000 dilution), and actin (Sigma-Aldrich; 1:1,000 dilution)]. Blots were quantified and analyzed using Quantity One software (Bio-Rad).
Statistical analysis. Values are means Ϯ SE. Statistical analyses were performed using one-way ANOVA followed by Tukey's post hoc test for multiple comparisons to identify statistical significance between groups. P Ͻ 0.05 was considered significant.
RESULTS
Adult cardiac myocytes are resistant to BNIP3-mediated cell death. Since the prodeath activity of BNIP3 has been found to differ in various cells, we investigated whether susceptibility to BNIP3-mediated cell death differs between neonatal and adult cardiac myocytes. Neonatal and adult myocytes were infected with an adenovirus encoding ␤-gal or BNIP3 to assess the effect on cell viability. Interestingly, we found that BNIP3 caused loss of mitochondrial membrane potential in a significant number of neonatal myocytes (Fig. 1, A and B) . In contrast, BNIP3 had no effect on mitochondrial membrane potential in adult myocytes (Fig. 1, A and B) . BNIP3 also compromised plasma membrane integrity, as measured by YO-PRO-1 uptake, in neonatal, but not adult, myocytes (Fig. 1,  C and D) . A dose-response experiment confirmed that adult cardiac myocytes were resistant to BNIP3-mediated cell death, even at much higher levels of BNIP3 infection (Fig. 1E) .
In addition, BNIP3 is a potent inducer of autophagy (10). We confirmed that induction of autophagy by BNIP3 was independent of loss of mitochondrial membrane potential and activation of cell death. Overexpression of BNIP3 led to a significant increase in autophagy as measured by an increase in the ratio of LC3-II to LC3-I in neonatal and adult cardiac myocytes (Fig. 2, A and B) . We also confirmed that BNIP3 caused an increase in the number of GFP-LC3-positive autophagosomes. The presence of bafilomycin A1 led to an additional increase in the number of autophagosomes in cells overexpressing BNIP3 (Fig. 2, C-F) , confirming that the increased number of autophagosomes reflected an increase in autophagic activity, rather than reduced flux.
Autophagy has been reported to protect against cell death by clearing damaged organelles and cytotoxic protein aggregates (27) . Therefore, we investigated whether the enhanced autophagy contributed to the resistance to BNIP3-mediated cell death in adult myocytes. Autophagy-related protein 5 (Atg5) is involved in elongation of the autophagosomes and is a critical component of autophagy (28) . We found that overexpression of Atg5-K130R, a dominant-negative of Atg5 (31), did not render the adult myocytes susceptible to BNIP3-mediated cell death (Fig. 3A) . Similarly, the presence of the pharmacological inhibitor of autophagy 3-methyladenine (3-MA) had no effect on cell viability, even in cells overexpressing BNIP3 (Fig. 3B) . This suggests that BNIP3 induces autophagy in neonatal and adult myocytes but that autophagy does not contribute to resistance to the prodeath activity of BNIP3 in adult cardiac myocytes.
A
Reduced antioxidant capacity contributes to increased sensitivity to BNIP3-mediated cell death. BNIP3 induces production of reactive oxygen species (ROS) (38) , which contributes to opening of the mitochondrial permeability transition pore and cell death. Thus we postulated that neonatal and adult myocytes possess different levels of antioxidant capacity that might influence their susceptibility to BNIP3. To investigate this possibility, we compared the levels of the antioxidant enzyme MnSOD in neonatal and adult myocytes. MnSOD is localized in the mitochondria and converts superoxide, a byproduct of oxidative phosphorylation, to H 2 O 2 and O 2 (14) . Interestingly, we found significantly higher levels of MnSOD expression in adult than neonatal cells (Fig. 4A) . To investigate if elevated MnSOD contributed to the resistance to BNIP3, we overexpressed MnSOD and BNIP3 in neonatal myocytes. We found that overexpression of MnSOD significantly suppressed BNIP3-induced cell death (Fig. 4, B and C) , confirming that increased levels of MnSOD antagonized the prodeath activity of BNIP3.
Next, we investigated whether MnSOD could protect against cell death mediated by endogenous BNIP3. BNIP3 is rapidly induced on exposure to hypoxia in neonatal myocytes (Fig. 5,  A and B) , which correlated with increased cell death (Fig. 5C) . Overexpression of BNIP3⌬TM, a dominant-negative of BNIP3 (33), or MnSOD significantly reduced hypoxia-mediated cell death (Fig. 5C ). This confirms that endogenous BNIP3 contributes to hypoxia-mediated cell death and that enhancing MnSOD levels is protective.
Inhibition of MnSOD restores susceptibility of adult cardiac myocytes to BNIP3-induced cell death. To further investigate if the elevated expression of MnSOD in adult myocytes provides resistance to BNIP3-mediated cell death, we assessed whether inhibition of MnSOD would increase sensitivity to BNIP3-mediated cell death. We found that the presence of 2-ME, a pharmacological inhibitor of MnSOD (16) , resulted in cell death in adult myocytes overexpressing BNIP3 (Fig. 6, A and  B) . The presence of the mitochondria-targeted ROS scavenger MitoTEMPO or MnTBAP, a MnSOD mimetic (25) , significantly reduced cell death in cells treated with 2-ME (Fig. 6C) . These results confirm that the enhanced antioxidant capacity of adult myocytes protects against BNIP3-induced cell death.
Increased oxidative stress promotes BNIP3-mediated cell death in adult myocytes. Studies have found that increased ROS leads to dimerization and activation of BNIP3 (15, 21) . To investigate whether additional oxidative stress is needed to activate the proapoptotic activity of BNIP3 in adult myocytes, we exposed adult myocytes overexpressing BNIP3 to H 2 O 2 . As expected, H 2 O 2 alone caused loss of mitochondrial membrane potential (Fig. 7, A and B) and cell death (Fig. 7C) in a significant number of cells. Interestingly, although BNIP3 overexpression alone had no effect on mitochondrial membrane potential and cell viability, addition of H 2 O 2 to these cells significantly augmented loss of mitochondrial membrane potential and cell death in adult myocytes compared with H 2 O 2 alone (Fig. 7) . These findings indicate that activation of BNIP3-mediated cell death is dependent on the redox status of the cell.
DISCUSSION
Although BNIP3 is known to play a role in various diseases, its exact function in cells is unclear. This is further complicated by recent data indicating that BNIP3 also regulates mitochondrial turnover under normal conditions (6, 9) . Interestingly, cells also differ in their susceptibility to BNIP3-mediated cell death, but the molecular basis for this difference is unknown. Our study reports the first evidence that adult myocytes are resistant to BNIP3-mediated cell death under nonstressed conditions and that this is due to their increased antioxidant defense. MnSOD is important in neutralizing superoxide, and also provide some insight into why pediatric patients are more vulnerable to ischemic injury during cardiac surgery. Antioxidant levels in the myocardium are known to follow a developmental pattern where levels of the major antioxidants, such as catalase, SOD, and glutathione, are lower in newborn than adult hearts (3, 26) . Our studies show that the reduced levels of MnSOD lead to increased susceptibility to BNIP3-mediated cell death in neonatal myocytes. We and others previously reported that neonatal myocytes express little or no BNIP3 under normal conditions (2, 10, 33) . Instead, during hypoxia, BNIP3 is rapidly upregulated in neonatal myocytes, where it perturbs mitochondrial function and activates cell death. Our data suggest that elevated BNIP3 is detrimental in neonatal myocytes due to the reduced ability to neutralize and defend against oxidants, such as H 2 O 2 and superoxide, that activate BNIP3.
Congenital heart disease in newborns and infants often requires corrective surgery for survival into adulthood. Such surgery involves cardiopulmonary bypass, which can lead to ischemic injury. It is also known that the younger the age of the patients, the more vulnerable they are to ischemic injury during surgical repair of the heart (12). Thus our data suggest that potential upregulation of BNIP3 during ischemia combined with the inability to neutralize excessive ROS production may be a key factor in the increased susceptibility to ischemic injury in pediatric patients. Additional studies are necessary for a full understanding of the underlying mechanisms of the increased susceptibility, so that therapies can be developed to limit the myocardial injury in pediatric patients.
In contrast to neonatal myocytes, BNIP3 is constitutively expressed in the adult heart (5, 10). Interestingly, recent findings suggest that BNIP3 plays an important role in mitochondrial maintenance in adult myocardium (6) . A similar function for BNIP3 has been reported in liver, where loss of BNIP3 leads to an increase in mitochondrial mass and the presence of dysfunctional mitochondria (9) . Clearly, there is an increased need to turn over aged and defective mitochondria in aging tissues, whereas this is less critical for homeostasis in the neonatal heart. The need to turn over mitochondria on a regular basis in adult cells would explain why BNIP3 is constitutively expressed in the adult, but not neonatal, heart. Adult myocytes are resistant to BNIP3-mediated cell death in the absence of additional oxidative stress, and our data demonstrate that there is still activation of autophagy in these cells by BNIP3. Autophagy can protect cells against activation of cell death by clearing dysfunctional mitochondria (20) , and we previously found that inhibition of autophagy in fibroblasts and HL-1 cells increases BNIP3-mediated cell death (10, 34) . Interestingly, in this study we observed that inhibition of autophagy in adult myocytes did not result in increased susceptibility to BNIP3-mediated cell death, suggesting that the enhanced autophagy is not a major contributor to resistance to BNIP3 under these conditions. It also suggests that the function of BNIP3-mediated autophagy in adult cardiac myocytes might differ from that in cells that are susceptible to BNIP3-mediated cell death.
Our data demonstrate clearly that oxidative stress plays a critical role in determining cell susceptibility to BNIP3-mediated cell death. There are no pharmacological inhibitors that specifically target only MnSOD, and the inhibitor that we used in this study also inhibits Cu,ZnSOD in the cytosol (16) . Similarly, MnTBAP also mimics both isoforms of SOD (7). Although BNIP3 and MnSOD are localized to the mitochondria and mitochondrial ROS are involved in activating cell death in myocytes overexpressing BNIP3, it is possible that the cytosolic Cu,ZnSOD also contributes to the resistance to BNIP3-mediated cell death in the adult myocytes. We recognize that this is a limitation of our study and that future studies using tissue-specific MnSOD conditional knockout mice are needed to examine the susceptibility of BNIP3 in adult myocytes.
Upregulation of BNIP3 in neonatal myocytes during ischemia appears to be a detrimental event that contributes to loss of myocytes. Thus the possibility of targeting BNIP3 to limit ischemic injury in patients undergoing cardiac surgery is very intriguing. Although BNIP3 represents an interesting potential therapeutic target to prevent activation of cell death, this protein also appears to be important in maintaining mitochondrial mass in cells. Thus further studies are necessary to enhance our understanding of how BNIP3 regulates cell death and mitochondrial autophagy in the immature and adult myocardium.
